The Immediate Physiological Effects of E-Cigarette Use and Exposure to Secondhand E-Cigarette Vapor.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
McClelland (2021)
a Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
McEwan (2022)
Plasma Nicotine Pharmacokinetics of Oral Nicotine Pouches across Varying Flavours and Nicotine Content *
Nonclinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
McEwen (2023)
Comparison of End Tidal Carbon Monoxide Levels between Conventional Cigarette, Electronic Cigarette and heated Tobacco Product among asiatic Smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Nga (2020)
a randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic profiles of cigarettes and e-cigarettes with nicotine salt formulations in US adult smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
O'Connell (2019)
Particle size distribution of selected electronic nicotine delivery system products
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Oldham (2018)
Nicotine delivery and user reactions to Juul EU (20 mg/ml) compared with Juul US (59 mg/ml), cigarettes and other e-cigarette products.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Phillips-Waller (2021)
Nicotine delivery and cigarette equivalents from vaping a JUULpod.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Prochaska (2022)
Effect of Puffing Behavior on Particle Size Distributions and Respiratory Depositions From Pod-Style Electronic Cigarette, or Vaping, Products.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Ranpara (2021)
Free Radical, Carbonyl, and Nicotine Levels Produced by Juul Electronic Cigarettes.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Reilly (2019)